Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
E

Failure to Store Medications per Manufacturer Instructions

Los Angeles, California Survey Completed on 06-27-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors observed that the facility failed to store certain medications according to manufacturer instructions. Specifically, one unopened vial of latanoprost eye drops intended for a resident was found stored at room temperature in a medication cart, rather than in the refrigerator as required by the product labeling. During an interview, the LVN confirmed that unopened latanoprost should be refrigerated and acknowledged that improper storage could affect the medication's effectiveness. Additionally, two unopened Lantus insulin pens for two other residents were found stored at room temperature in a medication cart, instead of being refrigerated as specified by the manufacturer. The LVN responsible for these medications confirmed that unopened insulin pens are supposed to be refrigerated until use and that improper storage or labeling could compromise their effectiveness. A review of the facility's medication storage policy indicated that medications and biologicals must be stored safely and properly, following manufacturer recommendations, including refrigeration when required.

An unhandled error has occurred. Reload 🗙